Quarterly report pursuant to Section 13 or 15(d)

Note 23 - Segment Information: Schedule of Segment Information (Details)

v3.10.0.1
Note 23 - Segment Information: Schedule of Segment Information (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Operating income (loss) $ (203,097) $ (186,981) $ (607,984) $ (848,668)  
Interest income 41,578 93,908 124,164 157,516  
Interest expense 3,588 3,434 11,587 10,951  
Total assets 8,157,760   8,157,760   $ 7,663,934
Cannabis and Medical Marijuana Segment          
Net revenue 101,407 5,040 598,539 9,800  
Operating income (loss) 32,257 4,654 151,566 8,729  
Interest income 18,850 71,219 62,759 88,541  
Interest expense 0 0 181 0  
Property additions 0 0 0 0  
Depreciation and amortization 0 0 0 0  
Total assets 4,270,527 3,122,165 4,270,527 3,122,165  
Facility Operations Related          
Net revenue 930,214 810,062 2,680,541 2,307,994  
Operating income (loss) 3,173 65,309 2,382 140,257  
Interest income 1 1 2 4  
Interest expense 4,713 4,567 14,704 14,353  
Property additions 13,484 0 13,484 0  
Depreciation and amortization 3,369 1,461 8,554 8,106  
Total assets 1,150,657 1,168,649 1,150,657 1,168,649  
Corporate and Eliminations          
Net revenue 0 0 0 0  
Operating income (loss) (238,527) (256,944) (761,932) (997,654)  
Interest income 22,727 22,688 61,403 68,971  
Interest expense (1,125) (1,133) (3,298) (3,402)  
Property additions 1,658 4,775 4,057 7,909  
Depreciation and amortization 2,059 1,088 5,530 2,496  
Total assets 2,736,576 3,057,673 2,736,576 3,057,673  
Consolidated          
Net revenue 1,031,621 815,102 3,279,080 2,317,794  
Operating income (loss) (203,097) (186,981) (607,984) (848,668)  
Interest income 41,578 93,908 124,164 157,516  
Interest expense 3,588 3,434 11,587 10,951  
Property additions 15,142 4,775 17,541 7,909  
Depreciation and amortization 5,428 2,549 14,084 10,602  
Total assets $ 8,157,760 $ 7,348,487 $ 8,157,760 $ 7,348,487